Article Text

PDF

Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment
  1. Peter M ten Klooster1,
  2. Martine M Veehof1,
  3. Erik Taal1,
  4. Piet L C M van Riel2,
  5. Mart A F J van de Laar1,3
  1. 1
    Institute for Behavioral Research, University of Twente, Enschede, The Netherlands
  2. 2
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  3. 3
    Department of Rheumatology, Medisch Spectrum Twente, Enschede, The Netherlands
  1. Peter M ten Klooster, Institute for Behavioral Research, Faculty of Behavioral Sciences, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands; p.m.tenklooster{at}utwente.nl

Abstract

Objectives: To examine priorities for health status improvement in patients with active rheumatoid arthritis (RA) during anti-tumour necrosis factor (TNF) treatment.

Methods: Data were used from 173 patients with RA starting treatment with TNF-blocking agents. Outcome measures included assessment of health status with the Arthritis Impact Measurement Scales 2 (AIMS2) at baseline and after 3 and 12 months. The AIMS2 contains a priority list from which patients are asked to select from 12 areas of health the 3 in which they would most like to see improvement.

Results: After 1 year of treatment, 10 out of 12 areas of health on the AIMS2 were significantly improved. The most commonly selected priorities for improvement at baseline were pain (88%), hand and finger function (57%), walking and bending (42%), mobility (33%), and work (29%). At group level, this priority ranking remained largely unchanged during treatment. After adjustment for multiple comparisons, only pain was selected significantly less often at 3 and 12 months (71% at both assessments). Within individual patients, however, priorities often changed. Changes in the priority of pain were related to the achieved level of patient-perceived pain and disease activity.

Conclusions: This study shows that, at the group level, patients’ priorities for improvement are fairly stable during 12 months of anti-TNF therapy, despite major improvements in health status. Although pain reduction becomes somewhat less important, it remains the most commonly selected priority. In contrast, individual patient priorities are not stable over the course of treatment and appear to be associated with differences in disease state.

  • rheumatoid arthritis
  • health status
  • pain
  • patient priorities

Statistics from Altmetric.com

Footnotes

  • Funding: This study was funded by an unrestricted educational grant by Schering-Plough and CVZ (the Dutch Health Care Insurance Board).

  • Abbreviations:
    AIMS2
    Arthritis Impact Measurement Scales
    DAS
    Disease Activity Score
    DREAM
    Dutch Rheumatoid Arthritis Anti-TNF Monitoring
    HAQ-DI
    Health Assessment Questionnaire Disability Index
    RA
    rheumatoid arthritis
    RADAI
    Rheumatoid Arthritis Disease Activity Index
    TNF
    tumour necrosis factor
    VAS-GH
    Visual Analogue Scale for General Health

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.